{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:38:33Z","timestamp":1790948313432,"version":"4.1.0"},"reference-count":54,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/mmr.2017.6589","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T12:07:31Z","timestamp":1494936451000},"page":"403-409","source":"Crossref","is-referenced-by-count":23,"title":["Contribution of methylglyoxal to delayed healing of bone injury in diabetes"],"prefix":"10.3892","volume":"16","author":[{"given":"Takao","family":"Aikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Ugaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Munesue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"key20180108005051_b1-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta- analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporosis Int"},{"key":"key20180108005051_b2-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bone.2008.10.042","article-title":"Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment","volume":"44","author":"Kayal","year":"2009","journal-title":"Bone"},{"key":"key20180108005051_b3-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1600-0501.2010.01923.x","article-title":"The effect of diabetes mellitus on osseous healing","volume":"21","author":"Retzepi","year":"2010","journal-title":"Clin Oral Implants Res"},{"key":"key20180108005051_b4-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/14740338.2012.639359","article-title":"Diabetes and fracture healing: The skeletal effects of diabetic drugs","volume":"11","author":"Simpson","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"key20180108005051_b5-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: The Rotterdam study","volume":"16","author":"de Liefde","year":"2005","journal-title":"Osteoporosis Int"},{"key":"key20180108005051_b6-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1359\/jbmr.070115","article-title":"Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity","volume":"22","author":"Kayal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key20180108005051_b7-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/jbmr.59","article-title":"TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1","volume":"25","author":"Kayal","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key20180108005051_b8-mmr-16-01-0403","first-page":"210","article-title":"The influence of diabetes mellitus on the healing of closed fractures","author":"Loder","year":"1988","journal-title":"Clin Orthop Relat Res"},{"key":"key20180108005051_b9-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005131-199906000-00008","article-title":"Early wound complications of operative treatment of calcaneus fractures: Analysis of 190 fractures","volume":"13","author":"Folk","year":"1999","journal-title":"J Orthop Trauma"},{"key":"key20180108005051_b10-mmr-16-01-0403","first-page":"12","article-title":"Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus","volume":"51","author":"Botushanov","year":"2009","journal-title":"Folia Med (Plovdiv)"},{"key":"key20180108005051_b11-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000281826","article-title":"Diabetes induced changes in rat mesenchymal stem cells","volume":"191","author":"Stolzing","year":"2010","journal-title":"Cells Tissues Organs"},{"key":"key20180108005051_b12-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138920007780866852","article-title":"Calcium metabolism and oxidative stress in bone fractures: Role of antioxidants","volume":"8","author":"Sheweita","year":"2007","journal-title":"Curr Drug Metab"},{"key":"key20180108005051_b13-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1433.044","article-title":"Pentosidine effects on human osteoblasts in vitro","volume":"1126","author":"Sanguineti","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"key20180108005051_b14-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","article-title":"Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways","volume":"40","author":"Alikhani","year":"2007","journal-title":"Bone"},{"key":"key20180108005051_b15-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"key20180108005051_b16-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01886793","article-title":"Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation end product-modified serum albumins","volume":"14","author":"Westwood","year":"1995","journal-title":"J Protein Chem"},{"key":"key20180108005051_b17-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1432-1033.1993.tb17638.x","article-title":"The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal","volume":"212","author":"Phillips","year":"1993","journal-title":"Eur J Biochem"},{"key":"key20180108005051_b18-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121743","article-title":"The glyoxalase pathway: The first hundred years\u2026 and beyond","volume":"453","author":"Silva","year":"2013","journal-title":"Biochem J"},{"key":"key20180108005051_b19-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0306-3623(95)02054-3","article-title":"Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy","volume":"27","author":"Thornalley","year":"1996","journal-title":"Gen Pharmacol"},{"key":"key20180108005051_b20-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-4274(99)00160-5","article-title":"Methylglyoxal in living organisms: Chemistry, biochemistry, toxicology and biological implications","volume":"110","author":"Kalapos","year":"1999","journal-title":"Toxicol Lett"},{"key":"key20180108005051_b21-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0009-2797(02)00212-0","article-title":"Methylglyoxal metabolism and diabetic complications: Roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase","volume":"143\u2013144","author":"Vander Jagt","year":"2003","journal-title":"Chem Biol Interact"},{"key":"key20180108005051_b22-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/cclm-2012-0878","article-title":"Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: Evaluation of blood specimen","volume":"52","author":"Scheijen","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"key20180108005051_b23-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3164\/jcbn.15-132","article-title":"Non-invasive measurement of skin autofluorescence to evaluate diabetic complications","volume":"58","author":"Yamanaka","year":"2016","journal-title":"J Clin Biochem Nutr"},{"key":"key20180108005051_b24-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1039\/C5FO01618E","article-title":"Salacia chinensis L. extract ameliorates abnormal glucose metabolism and improves the bone strength and accumulation of AGEs in type 1 diabetic rats","volume":"7","author":"Shirakawa","year":"2016","journal-title":"Food Funct"},{"key":"key20180108005051_b25-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"C132","DOI":"10.1152\/ajpcell.1999.277.1.C132","article-title":"Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid","volume":"277","author":"Otsuka","year":"1999","journal-title":"Am J Physiol"},{"key":"key20180108005051_b26-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/bbrc.1996.0411","article-title":"Effects of BMP-2, BMP-4 and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2\/PA6","volume":"220","author":"Yamaguchi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108005051_b27-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/10715762.2013.859387","article-title":"Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells","volume":"48","author":"Suh","year":"2014","journal-title":"Free Radic Res"},{"key":"key20180108005051_b28-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/cs0870021","article-title":"Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications","volume":"87","author":"McLellan","year":"1994","journal-title":"Clin Sci (Lond)"},{"key":"key20180108005051_b29-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mnfr.200400093","article-title":"Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress","volume":"49","author":"Lapolla","year":"2005","journal-title":"Mol Nutr Food Res"},{"key":"key20180108005051_b30-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1073\/pnas.95.10.5533","article-title":"Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells","volume":"95","author":"Chaplen","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108005051_b31-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jpba.2005.05.012","article-title":"A study of spectral integration and normalization in NMR-based metabonomic analyses","volume":"39","author":"Webb-Robertson","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"key20180108005051_b32-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jcb.21114","article-title":"Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2","volume":"100","author":"Chan","year":"2007","journal-title":"J Cell Biochem"},{"key":"key20180108005051_b33-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/154405910808700215","article-title":"Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis","volume":"87","author":"Ai-Aql","year":"2008","journal-title":"J Dent Res"},{"key":"key20180108005051_b34-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1359\/JBMR.050702","article-title":"Application of histomorphometric methods to the study of bone repair","volume":"20","author":"Gerstenfeld","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key20180108005051_b35-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5966\/sctm.2012-0031","article-title":"Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes","volume":"1","author":"Shin","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"key20180108005051_b36-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/dmrr.537","article-title":"Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats","volume":"21","author":"Follak","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"key20180108005051_b37-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/endo.135.2.8033826","article-title":"Stimulation of fracture repair by recombination human basic fibroblast growth factor in normal and streptozotocin-diabetic rats","volume":"135","author":"Kawaguchi","year":"1994","journal-title":"Endocrinology"},{"key":"key20180108005051_b38-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fendo.2015.00004","article-title":"The multifaceted role of the vasculature in endochondral fracture repair","volume":"6","author":"Bahney","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20180108005051_b39-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1358863X10367537","article-title":"Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes","volume":"15","author":"Liao","year":"2010","journal-title":"Vasc Med"},{"key":"key20180108005051_b40-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00223-012-9641-2","article-title":"Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis","volume":"91","author":"Okazaki","year":"2012","journal-title":"Calcif Tissu Int"},{"key":"key20180108005051_b41-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1021\/bi500046t","article-title":"The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs","volume":"53","author":"Xue","year":"2014","journal-title":"Biochemistry"},{"key":"key20180108005051_b42-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00018-005-5082-7","article-title":"Pyridoxamine as a multifunctional pharmaceutical: Targeting pathogenic glycation and oxidative damage","volume":"62","author":"Voziyan","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"key20180108005051_b43-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1523-1755.2002.00207.x","article-title":"Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat","volume":"61","author":"Degenhardt","year":"2002","journal-title":"Kidney Int"},{"key":"key20180108005051_b44-mmr-16-01-0403","first-page":"655","article-title":"Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats","volume":"5","author":"Zhu","year":"2012","journal-title":"Mol Med Rep"},{"key":"key20180108005051_b45-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/gfm589","article-title":"Renoprotective effects of the AGE-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats","volume":"23","author":"Waanders","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108005051_b46-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1046\/j.1523-1755.2003.00027.x","article-title":"The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats","volume":"63","author":"Alderson","year":"2003","journal-title":"Kidney Int"},{"key":"key20180108005051_b47-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.metabol.2006.08.026","article-title":"Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)\/Ta mice","volume":"56","author":"Tanimoto","year":"2007","journal-title":"Metabolism"},{"key":"key20180108005051_b48-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am J Nephrol"},{"key":"key20180108005051_b49-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2011030272","article-title":"Pyridorin in type 2 diabetic nephropathy","volume":"23","author":"Lewis","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key20180108005051_b50-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AJP.0b013e318272ebec","article-title":"Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: A randomized, double-blind, placebo-controlled study","volume":"29","author":"Garg","year":"2013","journal-title":"Clin J Pain"},{"key":"key20180108005051_b51-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0003-9861(02)00067-X","article-title":"Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: Characterization of a major product from the reaction of pyridoxamine and methylglyoxal","volume":"402","author":"Nagaraj","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"key20180108005051_b52-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0006-2952(99)00263-4","article-title":"Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation","volume":"58","author":"Ruggiero-Lopez","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"key20180108005051_b53-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"key20180108005051_b54-mmr-16-01-0403","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1371818","article-title":"Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes","volume":"122","author":"Kender","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T18:19:59Z","timestamp":1569349199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,16]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/mmr.2017.6589"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6589","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}